Empirical Asset Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Empirical Asset Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$902.69 - $993.35 $55,064 - $60,594	61 Added 17.63%	407 $391,000
Q4 2023 Jan 12, 2024	SELL	$775.18 - $881.7 $580,609 - $660,393	-749 Reduced 68.4%	346 $303,000
Q3 2023 Nov 01, 2023	BUY	$692.45 - $844.37 $76,169 - $92,880	110 Added 11.17%	1,095 $901,000
Q2 2023 Aug 01, 2023	BUY	$700.03 - $830.35 $38,501 - $45,669	55 Added 5.91%	985 $707,000
Q1 2023 Apr 18, 2023	BUY	$680.49 - $826.97 $161,276 - $195,991	237 Added 34.2%	930 $764,000
Q4 2022 Jan 31, 2023	SELL	$705.89 - $766.39 $239,296 - $259,806	-339 Reduced 32.85%	693 $499,000
Q3 2022 Oct 19, 2022	BUY	$573.97 - $724.32 $199,741 - $252,063	348 Added 50.88%	1,032 $711,000
Q2 2022 Jul 18, 2022	BUY	$548.35 - $738.84 $375,071 - $505,366	684 New	684 $404,000

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.4B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Empirical Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Empirical Asset Management, LLC with notifications on news.